Biological and clinical relevance of Laminin-5 in cancer (original) (raw)

• Liotta LA, Tryggvason K, Garbisa S et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67–8.
  Article PubMed CAS Google Scholar
• Mignatti P, Robbins E, Rifkin DB. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 1986; 47: 487–98.
  Article PubMed CAS Google Scholar
• Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996; 3: 895–904.
  Article PubMed CAS Google Scholar
• Itoh Y, Binner S, Nagase H. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J 1995; 308 ( Pt 2): 645–51.
  PubMed CAS Google Scholar
• Strongin AY, Collier I, Bannikov G et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270: 5331–38.
  Article PubMed CAS Google Scholar
• Imai K, Ohuchi E, Aoki T et al. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 1996; 56: 2707–10.
  PubMed CAS Google Scholar
• Fridman R, Fuerst TR, Bird RE et al. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem 1992; 267: 15398–405.
  PubMed CAS Google Scholar
• Deryugina EI, Bourdon MA, Reisfeld RA et al. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 1998; 58: 3743–50.
  PubMed CAS Google Scholar
• Itoh Y, Ito A, Iwata K et al. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. J Biol Chem 1998; 273: 24360–7.
  Article PubMed CAS Google Scholar
• Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541–73.
  Article PubMed CAS Google Scholar
• Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995; 55: 1856–62.
  PubMed CAS Google Scholar
• Basbaum CB, Werb Z. Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 1996; 8: 731–8.
  Article PubMed CAS Google Scholar
• Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature 1994; 370: 61–5.
  Article PubMed CAS Google Scholar
• Burgeson RE, Chiquet M, Deutzmann R et al. A new nomenclature for the laminins. Matrix Biol 1994; 14: 209–11.
  Article PubMed CAS Google Scholar
• Rousselle P, Golbik R, van der RM, Aumailley M. Structural requirement for cell adhesion to kalinin (laminin-5). J Biol Chem 1995; 270: 13766–70.
  Article PubMed CAS Google Scholar
• Marinkovich MP, Verrando P, Keene DR et al. Basement membrane proteins kalinin and nicein are structurally and immunologically identical. Lab Invest 1993; 69: 295–9.
  PubMed CAS Google Scholar
• Domloge-Hultsch N, Gammon WR, Briggaman RA et al. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 1992; 90: 1628–33.
  Article PubMed CAS Google Scholar
• Xia Y, Gil SG, Carter WG. Anchorage mediated by integrin alpha6beta4 to laminin 5 (epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kD protein. J Cell Biol 1996; 132: 727–40
  Article PubMed CAS Google Scholar
• Jones JC, Kurpakus MA, Cooper HM et al. A function for the integrin alpha 6 beta 4 in the hemidesmosome. Cell Regul 1991; 2: 427–38.
  PubMed CAS Google Scholar
• Gil SG, Brown TA, Ryan MC, Carter WG. Junctional epidermolysis bullosis: defects in expression of epiligrin/nicein/kalinin and integrin beta 4 that inhibit hemidesmosome formation. J Invest Dermatol 1994; 103: 31S–8S.
  Article PubMed CAS Google Scholar
• Meneguzzi G, Marinkovich MP, Aberdam D et al. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Exp Dermatol 1992; 1: 221–9.
  Article PubMed CAS Google Scholar
• Brown TA, Gil SG, Sybert VP et al. Defective integrin alpha 6 beta 4 expression in the skin of patients with junctional epidermolysis bullosa and pyloric atresia [published erratum appears in J Invest Dermatol 1997 Feb;108(2): 237]. J Invest Dermatol 1996; 107: 384–91.
  Article PubMed CAS Google Scholar
• McGrath JA, Pulkkinen L, Christiano AM et al. Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa [see comments]. J Invest Dermatol 1995; 104: 467–74.
  Article PubMed CAS Google Scholar
• Miyazaki K, Kikkawa Y, Nakamura A et al. A large cell-adhesive scatter factor secreted by human gastric carcinoma cells. Proc Natl Acad Sci USA 1993; 90: 11767–71.
  Article PubMed CAS Google Scholar
• Makela M, Larjava H, Pirila E et al. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res 1999; 251: 67–78.
  Article PubMed CAS Google Scholar
• Nguyen BP, Ryan MC, Gil SG et al. Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion [In Process Citation]. Curr Opin Cell Biol 2000; 12: 554–62.
  Article PubMed CAS Google Scholar
• Ryan MC, Tizard R, VanDevanter DR et al. Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair. J Biol Chem 1994; 269: 22779–87.
  PubMed CAS Google Scholar
• Giannelli G, Falk-Marzillier J, Schiraldi O et al. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997; 277: 225–8.
  Article PubMed CAS Google Scholar
• Hirosaki T, Mizushima H, Tsubota Y et al. Structural Requirement of Carboxyl-terminal Globular Domains of Laminin a3 Chain for Promotion of Rapid Cell Adhesion and Migration by Laminin-5. J Biol Chem 2000; 275: 22495–502
  Article PubMed CAS Google Scholar
• Salo S, Haakana H, Kontusaari S et al. Laminin-5 promotes adhesion and migration of epithelial cells: identification of a migrationrelated element in the gamma2 chain gene (LAMC2) with activity in transgenic mice. Matrix Biol 1999; 18: 197–210.
  Article PubMed CAS Google Scholar
• Koshikawa N, Giannelli G, Cirulli V et al. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000; 148: 615–24.
  Article PubMed CAS Google Scholar
• Gagnoux-Palacios L, Vailly J, Durand-Clement M et al. Functional re-expression of laminin-5 in laminin-gamma-2-deficient human keratinocytes modifies cell morphology, motility, and adhesion. J Biol Chem 1996; 271: 18437–44.
  Article PubMed CAS Google Scholar
• Grondahl-Hansen J, Christensen IJ, Rosenquist C et al. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 1993; 53: 2513–21.
  PubMed CAS Google Scholar
• Goldfinger LE, Stack MS, Jones JC. Processing of laminin-5 and its functional consequences: Role of plasmin and tissue-type plasminogen activator. J Cell Biol 1998; 141: 255–65.
  Article PubMed CAS Google Scholar
• Giannelli G, Pozzi A, Stetler-Stevenson WG et al. Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids. Am J Pathol 1999; 154: 1193–201.
  PubMed CAS Google Scholar
• Pyke C, Romer J, Kallunki P et al. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 1994; 145: 782–91.
  PubMed CAS Google Scholar
• Pyke C, Salo S, Ralfkiaer E et al. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995; 55: 4132–9.
  PubMed CAS Google Scholar
• Koshikawa N, Moriyama K, Takamura H et al. Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells. Cancer Res 1999; 59: 5596–601.
  PubMed CAS Google Scholar
• Kosmehl H, Berndt A, Strassburger S et al. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer 1999; 81: 1071–9.
  Article PubMed CAS Google Scholar
• Ono Y, Nakanishi Y, Ino Y et al. Clinico-pathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: immunohistochemical analysis of 67 lesions. Cancer 1999; 85: 2315–21.
  Article PubMed CAS Google Scholar
• Maatta M, Soini Y, Paakko P et al. Expression of the laminin gamma2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization. J Pathol 1999; 188: 361–8.
  Article PubMed CAS Google Scholar
• Soini Y, Maatta M, Salo S et al. Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma. J Pathol 1996; 180: 290–4.
  Article PubMed CAS Google Scholar
• Skyldberg B, Salo S, Eriksson E et al. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999; 91: 1882–7.
  Article PubMed CAS Google Scholar
• Albini A, Iwamoto Y, Kleinman HK et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239–45.
  PubMed CAS Google Scholar
• Fukushima Y, Ohnishi T, Arita N et al. Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. Int J Cancer 1998; 76: 63–72.
  Article PubMed CAS Google Scholar
• Martin KJ, Kwan CP, Nagasaki K et al. Down-regulation of laminin-5 in breast carcinoma cells. Mol Med 1998; 4: 602–13.
  PubMed CAS Google Scholar
• Henning K, Berndt A, Katenkamp D et al. Loss of laminin-5 in the epithelium-stroma interface: An immunohistochemical marker of malignancy in epithelial lesions of the breast. Histopathology 1999; 34: 305–9.
  Article PubMed CAS Google Scholar
• Hao J, Yang Y, McDaniel KM et al. Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am J Pathol 1996; 149: 1341–9.
  PubMed CAS Google Scholar
• Giannelli G, Bergamini C, Fransvea E et al. Human hepatocellular carcinoma (HCC) cells require both _α_3_β_1 integrin and matrix metalloproteinases activity for migration and invasion. Lab Invest 2001; 81: 613–27
  PubMed CAS Google Scholar
• Sordat I, Rousselle P, Chaubert P et al. Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment. Int J Cancer 2000; 88: 708–17.
  Article PubMed CAS Google Scholar